BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 37917161)

  • 1. Does total omentectomy prevent peritoneal seeding for advanced gastric cancer with serosal invasion?
    Jeong SA; Kim S; Lee IS; Yoo MW; Kim BS
    Surg Endosc; 2024 Jan; 38(1):97-104. PubMed ID: 37917161
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of total versus partial omentectomy for advanced gastric cancer in laparoscopic gastrectomy.
    Kim DJ; Lee JH; Kim W
    World J Surg Oncol; 2014 Mar; 12():64. PubMed ID: 24669875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparing surgical and oncologic outcomes between laparoscopic gastrectomy and open gastrectomy in advanced gastric cancer with serosal invasion: A retrospective study with propensity score matching.
    Jeong SA; Yoo MW; Lee IS; Gong CS; Ko CS; Jheong JH; Lee JB; Kim BS
    Eur J Surg Oncol; 2022 Sep; 48(9):1988-1993. PubMed ID: 35637096
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overall Survival Advantage of Omentum Preservation Over Omentectomy for Advanced Gastric Cancer: A Systematic Review and Meta-Analysis.
    Kong M; Chen H; Zhang R; Sheng H; Li L
    World J Surg; 2022 Aug; 46(8):1952-1961. PubMed ID: 35462593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is Total Omentectomy Mandatory in T3 and T4a Gastric Cancer for Laparoscopic Distal Gastrectomy?
    Lee H; Kim DJ; Lee HH; Lee J; Jun KH; Song KY; Chin HM; Kim JJ; Kim W
    Ann Surg Oncol; 2023 Jan; 30(1):289-297. PubMed ID: 35997904
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative dissemination during gastrectomy for gastric cancer associated with serosal invasion.
    Tokumitsu Y; Yoshino S; Iida M; Yoshimura K; Ueno T; Hazama S; Oka M
    Surg Today; 2015 Jun; 45(6):746-51. PubMed ID: 25115929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omentum preservation as an oncologically comparable and surgically superior alternative to total omentectomy during radical gastrectomy for T3-T4 gastric cancer.
    Seo WJ; Choi S; Roh CK; Cho M; Kim YM; Kim HI; Hyung WJ
    Surgery; 2021 Aug; 170(2):610-616. PubMed ID: 33714618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laparoscopy-assisted versus open D2 radical gastrectomy for advanced gastric cancer without serosal invasion: a case control study.
    Chen QY; Huang CM; Lin JX; Zheng CH; Li P; Xie JW; Wang JB; Lu J
    World J Surg Oncol; 2012 Nov; 10():248. PubMed ID: 23158876
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Partial Omentectomy in Laparoscopic Distal Gastrectomy for pT3-T4a Stage Gastric Cancer.
    Song M; Jiang Y; Liu Y; Li Z
    Int J Gen Med; 2023; 16():4681-4690. PubMed ID: 37868814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should total omentectomy be performed for advanced gastric cancer?: The role of omentectomy during laparoscopic gastrectomy for advanced gastric cancer.
    Lee S; Suh YS; Kang SH; Won Y; Park YS; Ahn SH; Kim HH
    Surg Endosc; 2022 Sep; 36(9):6937-6948. PubMed ID: 35141774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of a risk-scoring system to evaluate the serosal invasion for macroscopic serosal invasion positive gastric cancer patients.
    Wang PL; Huang JY; Zhu Z; Gong BC; Huang HW; Duan SJ; Xu HM; Liu FN
    Eur J Surg Oncol; 2018 May; 44(5):600-606. PubMed ID: 29454557
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of Serosal Changes Predicts Peritoneal Recurrence and Poor Prognosis After Curative Surgery for Gastric Cancer.
    Kang Y; Li S; Ge Q; Liu X; Yang Z; Xue Y; Wang F
    Medicine (Baltimore); 2015 Oct; 94(42):e1750. PubMed ID: 26496292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Complete omentectomy and extensive lymphadenectomy with gastrectomy improves the survival of gastric cancer patients with metastases in the adjacent peritoneum.
    Hagiwara A; Sawai K; Sakakura C; Shirasu M; Ohgaki M; Yamasaki J; Togawa T; Takahashi T
    Hepatogastroenterology; 1998; 45(23):1922-9. PubMed ID: 9840177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term outcomes of omentum-preserving versus resecting gastrectomy for locally advanced gastric cancer with propensity score analysis.
    Sakimura Y; Inaki N; Tsuji T; Kadoya S; Bando H
    Sci Rep; 2020 Oct; 10(1):16305. PubMed ID: 33004919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between area of serosal invasion and intraperitoneal free cancer cells in patients with gastric cancer.
    Ikeguchi M; Oka A; Tsujitani S; Maeta M; Kaibara N
    Anticancer Res; 1994; 14(5B):2131-4. PubMed ID: 7840512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of Subclassification of Serosal Invasion on the Survival of Patients With T4a Gastric Cancer.
    Nakamura K; Tajima K; Kanamori K; Yatabe K; Ogimi M; Higuchi T; Yamamoto M; Hara H; Kazuno A; Nabeshima K; Nomura E; Koyanagi K
    In Vivo; 2022; 36(4):1923-1929. PubMed ID: 35738632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omentectomy as Part of Radical Surgery for Gastric Cancer: 5-Year Follow-Up Results of a Multicenter Prospective Cohort Study.
    Keywani K; Borgstein ABJ; Boerma D; van Esser S; Eshuis WJ; Van Berge Henegouwen MI; van Sandick J; Gisbertz SS
    Dig Surg; 2023; 40(1-2):76-83. PubMed ID: 37231877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study.
    Hasegawa S; Kunisaki C; Ono H; Oshima T; Fujii S; Taguri M; Morita S; Sato T; Yamada R; Yukawa N; Rino Y; Masuda M
    Gastric Cancer; 2013 Jul; 16(3):383-8. PubMed ID: 22983455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical utility of perioperative staging laparoscopy for advanced gastric cancer.
    Ishigami S; Uenosono Y; Arigami T; Yanagita S; Okumura H; Uchikado Y; Kita Y; Kurahara H; Kijima Y; Nakajo A; Maemura K; Natsugoe S
    World J Surg Oncol; 2014 Nov; 12():350. PubMed ID: 25407392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bursectomy versus omentectomy alone for resectable gastric cancer (JCOG1001): a phase 3, open-label, randomised controlled trial.
    Kurokawa Y; Doki Y; Mizusawa J; Terashima M; Katai H; Yoshikawa T; Kimura Y; Takiguchi S; Nishida Y; Fukushima N; Iwasaki Y; Kaji M; Hirao M; Katayama H; Sasako M
    Lancet Gastroenterol Hepatol; 2018 Jul; 3(7):460-468. PubMed ID: 29709558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.